GlassScriptPhysician profile
Jacob M Redel
NPI 1588954655
$2,135.38
in general payments reported to CMS, 2019-2025
16 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,051 · 2022: $145 · 2023: $284 · 2024: $373 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.14 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk As | $1,051.23 | 2019 | |
| Sanofi-Aventis U.S. LLC | $184.95 | 2023-2025 | |
| Ascendis Pharma Endocrinology INC | $151.14 | 2022-2023 | |
| Tandem Diabetes Care, INC. | $135.12 | 2023-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $124.56 | 2023-2025 | Sogroya |
| Xeris Pharmaceuticals, INC. | $94.51 | 2023-2025 | Gvoke Hypopen |
| Pfizer INC. | $78.71 | 2024-2025 | |
| Abbvie INC. | $65.66 | 2024 | |
| Neurocrine Biosciences, INC. | $52.43 | 2025 | |
| Tolmar, INC. | $49.25 | 2023-2024 | |
| Dexcom, INC. | $37.27 | 2023-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $28.10 | 2022-2023 | Minimed 780g |
| Rhythm Pharmaceuticals, INC. | $27.46 | 2023 | Imcivree |
| Insulet Corporation | $23.81 | 2023 | Omnipod |
| Amphastar Pharmaceuticals, INC. | $17.79 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Redel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.